Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 4Smoking Cessation 2Uterine Cervical Neoplasms 1Prostatic Neoplasms 1Patient Compliance 1Papillomavirus Infections 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Lung Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms 1Chronic Pain 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

pembrolizumab 89Carboplatin 79Specimen Handling 76Magnetic Resonance Spectroscopy 63Pemetrexed 60Cisplatin 48durvalumab 44Paclitaxel 38Nivolumab 34atezolizumab 32osimertinib 29Radiotherapy 29Radiosurgery 29Biopsy 26Blood Specimen Collection 25Gemcitabine 24Docetaxel 24Immunoglobulin G 23Disulfides 22Standard of Care 21Drug Therapy 21Etoposide 19Taxes 18Radiation 18Practice Guidelines as Topic 18Educational Status 16130-nm albumin-bound paclitaxel 15X-Rays 14Surveys and Questionnaires 14Bevacizumab 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lung Neoplasms × Motivational Interviewing × 1 year × Clear all
NCT06912113 2026-02-20

The Effect of Motivational ınterviewing on ıntention to Quit Smoking in Lung Cancer Patients

University of Gaziantep

Phase NA Completed
42 enrolled
Thoracic

Lung Neoplasms, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡